| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9225674 | Journal of Allergy and Clinical Immunology | 2005 | 8 Pages |
Abstract
The transgenic products under testing seem to be safe in terms of allergenic potential. We propose postmarket testing as an important screening strategy for putative allergic sensitization to proteins introduced in transgenic plants.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Rita BSc, Baltazar MSc, Manuela Carmo, Carlos PharmD, Helena São José, António Bugalho MD, PhD, Alda MD, Leonor MD, PhD, Cândido Pinto PhD, Maria Margarida PhD,